Serial monitoring of EGFR mutations in plasma and evaluation of EGFR mutation status in matched tissue and plasma from NSCLC patients treated with CO-1686. Sun, J., Karlovich, C., Wen, W., Wakelee, H., Chien, S., Mann, E., O'Donne, P., Angenendt, P., Dziadziuszko, R., Horn, L., Spige, D. R., Sequist, L., Soria, J., Solomon, B., Camidge, D., Goldman, J., Gadgeel, S. M., Raponi, M., Wu, L., Park, K. AMER ASSOC CANCER RESEARCH. 2013

View details for DOI 10.1158/1535-7163.TARG-13-B25

View details for Web of Science ID 000209496800248